Cleared Dual Track

K230802 - Xprecia Prime Coagulation System (FDA 510(k) Clearance)

Mar 2024
Decision
358d
Days
Class 2
Risk

K230802 is an FDA 510(k) clearance for the Xprecia Prime Coagulation System. This device is classified as a Test, Time, Prothrombin (Class II - Special Controls, product code GJS).

Submitted by Universal Biosensors Pty, Ltd. (Rowville, AU). The FDA issued a Cleared decision on March 15, 2024, 358 days after receiving the submission on March 23, 2023.

This device falls under the Hematology FDA review panel. Regulated under 21 CFR 864.7750.

Submission Details

510(k) Number K230802 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 23, 2023
Decision Date March 15, 2024
Days to Decision 358 days
Submission Type Dual Track
Review Panel Hematology (HE)
Summary Summary PDF

Device Classification

Product Code GJS - Test, Time, Prothrombin
Device Class Class II - Special Controls
CFR Regulation 21 CFR 864.7750